Prognostic Value of Oxygen-15 Water PET in Coronary Artery Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 40000 participants.

Also called NCT07932314

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 3
Enrolled
  • 40,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07932314
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07932314. Allocation not applicable; no masking; primary purpose diagnostic. Start 2026-12 (anticipated); primary completion 2036-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prognostic Value of Oxygen-15 Water PET in Coronary Artery Disease
Acronym
AQUA COR
Condition
Microvascular Coronary Artery Disease
Condition
Microvascular Coronary Dysfunction
Intervention (Drug)
Oxygen-15 Water
Lead sponsor
Vastra Gotaland Region (class: other government)
Collaborator
Sahlgrenska University Hospital (class: other)
Collaborator
Gothia Forum - Center for Clinical Trial (class: other)

Record details

Record id
cardio:ct-nct07932314
Content hash
94f7164940f083de6e59f116ab633ee29fbaf1824d60b3b0de5156e886781f65